Henlius, Intas

Henlius e Intas reciben la opinión positiva del CHMP para HETRONIFLY® en los mercados europeos

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

Accord Healthcare Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

en | boerse | 67964190 |